Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 12, 2002, Pages 5737-5745

  Veldhuis, Johannes D ^a,c   Bidlingmaier, M ^b   Anderson, S M ^a   Evans, W S ^a   Wu, Z ^b   Strasburger, C J ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; PEGVISOMANT; PLACEBO; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; DRUG MEGADOSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STEADY STATE;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; KINETICS; MALE; PROSPECTIVE STUDIES; RECEPTORS, SOMATOTROPIN; RECOMBINANT PROTEINS; REFERENCE VALUES;

EID: 0036925959     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-011885     Document Type: Article

References (43)

1. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: Purification, cloning, and expression. Nature 330:537-543
2. Carter-Su C, Schwartz J, Smit LS 1996 Molecular mechanism of growth hormone action. Annu Rev Physiol 58:187-207
3. Cunningham BC, Wells JA 1991 Rational design of receptor-specific variants of human growth hormone. Proc Natl Acad Sci USA 88:3407-3411
4. DeVos AM, Ultsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306-312
5. Cunningham BC, Ultsch M, DeVos AM, Mulkerrim MG, Clauser KR, Wells JA 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-825
6. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamok K, Wagner TE, Baumann G, Kopchick JJ 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220
7. Fuh G, Cunningham BC, Fukunaga R, Nagata S, Goeddel DV, Wells JA 1992 Rational design of potent antagonists to the human growth hormone receptor. Science 256:1677-1680
8. Harding PA, Wang X, Okada S, Chen WY, Wan W, Kopchick JJ 1996 Growth hormone (GH) and a GH antagonist promote GH receptor dimerization and internalization. J Biol Chem 271:6708-6712
9. Baumann G 1991 Growth hormone heterogeneity: Genes, isohormones, variants, and binding proteins. Endocr Rev 12:424-449
10. Ross RJ, Leung KC, Maamra M, Bennett W, Doyle N, Water MJ, Ho KK 2001 Binding and functional studies with the growth hormone receptor antagonist, B2036-PEG (pegvisomant), reveal effects of pegylation and evidence that it binds to a receptor dimer. J Clin Endocrinal Metab 86:1716-1723
11. Johnson V, Maack T 1977 Renal extraction, filtration, absorption, and catabolism of growth hormone. Am J Physiol 233:F185-F196
12. Cameron DP, Burger HG, Catt KJ, Gordon E, Watts JMCK 1972 Metabolic clearance of human growth hormone in patients with hepatic and renal failure and in the isolated perifused pig liver. Metabolism 21:895-904
13. Haffner D, Schaefer F, Girard J, Ritz E, Mehls O 1994 Metabolic clearance of recombinant human growth hormone in health and chronic renal failure. J Clin Invest 93:1163-1171
14. Cuneo RC, Hickman P, Wallace JD, Teh BT, Ward G, Veldhuis JD, Waters MJ 1995 Altered endogenous growth factor (GH) secretory kinetics and diurnal GH-binding protein profiles in adults with chronic liver disease. Clin Endocrinol 43:265-275
15. Schaefer F, Baumann G, Faunt LM, Haffner D, Johnson ML, Mercado M, Ritz E, Mehls O, Veldhuis JD 1996 Multifactorial control of the elimination kinetics of unbound (free) GH in the human: Regulation by age, adiposity, renal function, and steady-state concentrations of GH in plasma. J Clin Endocrinol Metab 81:22-31
16. Rabkin R, Pimstone BL, Marks T, Eales L 1972 Disappearance of human growth hormone in the anephric non-uraemic and uraemic rat. Horm Metab Res 4:467-474
17. Veldhuis JD, Faunt LM, Johnson ML 1994 Analysis of nonequilibrium dynamics of bound, free, and total plasma ligand concentrations over time following nonlinear secretory inputs: Evaluation of the kinetics of two or more hormones pulsed into compartments containing multiple variable-affinity binding proteins. Methods Enzymol 240:349-377
18. Shah N, Aloi J, Evans WS, Veldhuis JD 1999 Time-mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations rather than sex, estradiol, or menstrual-cycle stage primarily determine the GH elimination rate in healthy young women and men. J Clin Endocrinol Metab 84:2862-2869
19. Husman B, Gustafsson JA, Andersson G 1988 Receptor-mediated endocytosis and degradation of bovine growth hormone in rat liver. Mol Cell Endocrinol 59:13-25
20. Bullier-Picard F, Postel-Vinay MC, Kayser C 1989 In vivo uptake of human growth hormone in male rat liver. J Endocrinol 121:19-25
21. Catalina PF, Andrade MA, Garcia-Mayor RV, Mallo F 2002 Altered GH elimination kinetics in type 1 diabetes mellitus can explain the elevation in circulating levels: Bicompartmental approach. J Clin Endocrinol Metab 87:1785-1790
22. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of GH secretion in experimental animals and the human. Endocr Rev 19:717-797
23. Veldhuis JD, Johnson ML, Faunt LM, Mercado M, Baumann G 1993 Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. J Clin Invest 91:629-641
24. Chen WY, Chen NY, Yun J, Wight DC, Wang XZ, Wagner TE, Kopchick JJ 1995 Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity. Mol Endocrinol 9:292-302
25. Segev Y, Landau D, Rasch R, Flyvbjerg A, Phillip M 1999 Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice. J Am Soc Nephrol 10:2374-2381
26. Smith LE, Kopchick JJ, Chen W, Knapp J, Kinose F, Daley D, Foley E, Smith RG, Schaeffer JM 1997 Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709
27. Muller AF, Janssen JA, Hofland LJ, Lamberts SW, Bidlingmaier M, Strasburger CJ, van der Lely AJ 2001 Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J Clin Endocrinol Metab 86:590-593
28. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis R J 2000 Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med 342:1171-1177
29. Ross RJ, Esposito N, Shen XY, Von Laue S, Chew SL, Dobson PR, Postel-Vinay MC, Finidori J 1997 A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol Endocrinol 11:265-273
30. Veldhuis JD, Bidlingmaier M, Anderson SM, Wu Z, Strasburger CJ 2001 Lowering total plasma IGF-I concentrations by way of a novel, potent and selective GH-receptor antagonist, pegvisomant (B2036-PEG), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men. J Clin Endocrinol Metab 86:3304-3310
31. Trainer PJ, Drake WM, Perry LA, Taylor NF, Besser GM, Monson JP 2001 Modulation of cortisol metabolism by the growth hormone receptor antagonist pegvisomant in patients with acromegaly. J Clin Endocrinol Metab 86:2989-2992
32. Okada S, Chen WY, Wiehl P, Kelder B, Goodman HM, Guller S, Sonenberg M, Kopchick JJ 1992 A growth hormone (GH) analog can antagonize the ability of native GH to promote differentiation of 3T3-F442A preadipocytes and stimulate insulin-like and lipolytic activities in primary rat adipocytes. Endocrinology 130:2284-2290
33. Veldhuis JD, Carlson ML, Johnson ML 1987 The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84:7686-7690
34. Veldhuis JD, Johnson ML 1992 Deconvolution analysis of hormone data. Methods Enzymol 210:539-575
35. Veldhuis JD, Fraioli F, Rogol AD, Dufau ML 1986 Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest 77:1122-1128
36. Straume M, Veldhuis JD, Johnson ML 1994 Model-independent quantification of measurement error: Empirical estimation of discrete variance function profiles based on standard curves. Methods Enzymol 240:121-150
37. Hansen TK, Jorgensen JOL, Christiansen JS 2002 Body composition and circulating levels of insulin, insulin-like growth factor-binding protein-1 and growth hormone (GH)-binding protein affect the pharmacokinetics of GH in adults independently of age. J Clin Endocrinol Metab 87:2185-2196
38. Turner TT, Rhoades CP 1995 Testicular capillary permeability: The movement of luteinizing hormone from the vascular to the interstitial compartment. J Androl 16:417-423
39. Ghinea N, Mai TV, Groyer-Picard MT, Milgrom E 1994 How protein hormones reach their target cells. Receptor-mediated transcytosis of hCG through endothelial cells. J Cell Biol 125:87-97
40. Yang YJ, Hope ID, Ader M, Bergman RN 1989 Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 84:1620-1628
41. Schwartz MW, Bergman RN, Kahn SE, Taborsky Jr GJ, Fisher LD, Sipols AJ, Woods SC, Steil GM, Porte D 1991 Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport. J Clin Invest 88:1272-1281
42. Wiren L, Bengtsson BA, Johannsson G 1998 Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency. Clin Endocrinol 48:613-620
43. Guyton AC, Hall JE 2000 The body fluid compartments: Extracellular and intracellutar fluids; interstitial fluid and edema. In: Textbook of Medical Physiology, vol 10. Philadelphia: WB Saunders Co.; 264-278